SELECTRAP Trademark

Trademark Overview


On Monday, March 13, 2023, a trademark application was filed for SELECTRAP with the United States Patent and Trademark Office. The USPTO has given the SELECTRAP trademark a serial number of 79367019. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, July 5, 2024. This trademark is owned by Y-Biologics Inc.. The SELECTRAP trademark is filed in the Pharmaceutical Products category with the following description:

Immunostimulants; pharmaceutical preparations for treating malignant tumors; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes, namely, the treatment of cancer and biological preparations containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; polyclonal antibodies for medical purposes; pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and pharmaceuticals containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutica...
selectrap

General Information


Serial Number79367019
Word MarkSELECTRAP
Filing DateMonday, March 13, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, July 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesImmunostimulants; pharmaceutical preparations for treating malignant tumors; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes, namely, the treatment of cancer and biological preparations containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; polyclonal antibodies for medical purposes; pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and pharmaceuticals containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology; tumor suppressing agents; monoclonal antibodies for medical purposes; bispecific antibodies for the treatment of medical conditions; bispecific antibodies for medical purposes; antibody pharmaceuticals for treating cancer; antibody diagnostic reagents for medicinal use; antibody diagnostic reagents for medical purposes; antibody reagents for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameY-Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Friday, April 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 14, 2023APPLICATION FILING RECEIPT MAILED
Monday, December 11, 2023ASSIGNED TO EXAMINER
Monday, December 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 15, 2023REFUSAL PROCESSED BY MPU
Friday, December 15, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 8, 2024REFUSAL PROCESSED BY IB
Friday, June 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 5, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 5, 2024SUSPENSION LETTER WRITTEN
Friday, July 5, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, September 4, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, September 4, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, September 20, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB